Addendum

     
05/08/2020
06/08/2020
11/08/2020
Brazil
The content of the Periodic Report of Evaluation of Risk-Benefit provided by the medicine registration holder

The Draft Resolution number 552, 3 September 2018 – previously notified through G/TBT/N/BRA/843 – which establishes the content of the Periodic Report of Evaluation of Risk-Benefit provided by the medicine registration holder, was adopted as Normative Instruction number 63, 22 July 2020.

Language Attachments  
There are currently no attachments
 
 
22/07/2020
 
 
 
 
 
 
 

Medicines

Médicaments

medicines

Version Products covered Interpreted
There are currently no items in the database.
Products covered Interpreted
11.120.10 - Medicaments No

Protection of human health or safety

Protection de la santé ou de la sécurité des personnes
protección de la salud o seguridad humanas.

Notification objective













Notified Under Article

 
 
 
 
 
 
 

Related notifications